Experienced, tenacious, and always trial-ready, we are committed to understanding complex legal challenges that impact the future of our clients’ businesses, globally.
Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.
With a strong culture of diversity, equity, and inclusion, we build relationships with our clients and colleagues alike, helping communities and acting with purpose. Our client service, entrepreneurialism, and inquisitive nature sit at the heart of the firm, enabling us to prioritize client goals and achieve successful outcomes.
Jeny M. Maier’s articles from Axinn Veltrop & Harkrider are most popular:
within Antitrust/Competition Law topic(s)
Axinn Veltrop & Harkrider are most popular:
in Asia
ABA Our Curious Amalgam
Axinn managing partner Jeny
Maier co-hosted ABA's Our Curious Amalgam podcast
in an episode entitled, "What's Up With U.S. Merger
Remedies?"
Jeny spoke with Dan Ducore, former Assistant Director of the
Federal Trade Commission's Bureau of Competition Compliance
Division, to discuss the growing skepticism towards merger remedies
by the U.S. antitrust authorities.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
